Earnings Call · Q2 FY2026·2026-07-28

Q2 26EPS +21.43%·Rev n/aQ1 26EPS +14.29%·Rev n/aQ4 25EPS +29.03%·Rev n/aQ3 25EPS +26.67%·Rev n/a⚠ consensus missing

Nautilus Biotechnology, Inc. NAUT

Chi-Yan Ig — Investor Relations, The Gilmartin Group

Sujal Patel — Co-founder and Chief Executive Officer, Nautilus Biotechnology

Parag Mallick — Co-founder and Chief Scientist, Nautilus Biotechnology

Anna Mowry — Chief Financial Officer, Nautilus Biotechnology

−27.7%1d on move date3d−38.0%5d−39.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NAUT calls or request research access.

More NAUT calls Browse calls Request research access